miR-133a-3p修饰间充质干细胞外泌体促进大鼠急性心肌梗死后心肌修复
该研究在大鼠急性心肌梗死模型中,于梗死区边缘原位注射miR-133a-3p修饰的人源脐带血间充质干细胞外泌体,28天后与阴性对照外泌体相比,左心室射血分数升高、心肌纤维化面积和凋亡率降低、CD31和α-SMA阳性血管增多,提示该外泌体可抑制心肌凋亡、促进血管新生并改善心功能。
要点
- miR-133a-3p-Exo组28天左心室射血分数高于miR-NC-Exo组。
- miR-133a-3p-Exo组心肌纤维化面积和凋亡率均低于对照。
- miR-133a-3p-Exo组CD31及α-SMA阳性血管数量显著增多。
核心结论
- miR-133a-3p修饰的ucMSC来源外泌体可抑制梗死后心肌凋亡、促进血管新生,改善大鼠AMI后心功能。
研究设计与样本
- 体外扩增培养ucMSC,用携带miR-133a-3p或阴性对照的慢病毒转染,分别提取外泌体miR-133a-3p-Exo与miR-NC-Exo。
- 采用冠状动脉左前降支结扎术构建大鼠AMI模型,于梗死区边缘原位注射上述外泌体,干预28天后评估。
主要发现
- 与miR-NC-Exo组相比,miR-133a-3p-Exo组左心室射血分数较高[(64.2%±8.9%)比(47.4%±9.8%),P<0.05]。
- miR-133a-3p-Exo组心肌纤维化面积较低[(18.0%±1.5%)比(31.2%±7.3%),P<0.01]。
- miR-133a-3p-Exo组凋亡率较低[(15.1%±4.4%)比(25.6%±3.6%),P<0.05]。
- 梗死边缘区CD31阳性血管较多[(13.9±2.0)条比(2.9±0.9)条,P<0.000 1]。
- α-SMA阳性血管较多[(11.0±1.6)条比(3.5±0.9)条,P<0.000 1]。
临床怎么用
- 该结果为大鼠AMI模型的临床前研究,提示miR-133a-3p修饰ucMSC外泌体可能作为梗死后心肌修复的候选策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effects of exosome derived from miR-133a-3p engineered human umbilical cord blood mesenchymal stem cells (ucMSC) on myocardial repair after acute myocardial infarction (AMI) in rats. Methods: UcMSC was amplified and cultured in vitro. Lentiviral carrying miR-133a-3p and negative control vectors were transfected into ucMSC. Exosomes secreted by the transfected ucMSC were named miR-133a-3p-Exo and miR-NC-Exo, respectively. The AMI model of rats was established by ligation of the left anterior descending coronary artery. MiR-133a-3p-Exo or miR-NC-Exo were then injected into the border zone of the infarct area. Cardiac function was assessed by echocardiography after twenty-eight days of intervention, and Masson staining was used to evaluate the area of myocardial fibrosis post-AMI. The myocardial apoptosis after infarction was evaluated by TUNEL staining and the angiogenesis after infarction was evaluated by immunofluorescence staining in the current study. Results: Compared with the miR-NC-Exo group, the left ventricular ejection fraction in the miR-133a-3p-Exo group was significantly increased ((47.4%±9.8%) vs. (64.2%±8.9%), P<0.05). While the myocardial fibrosis area ((31.2%±7.3%) vs. (18.0%±1.5%), P<0.01) and the percentage of apoptotic cardiomyocytes ((25.6%±3.6%) vs. (15.1%±4.4%), P<0.05) was significantly reduced in the miR-133a-Exo group. Besides, the expression of CD31 and α-smooth muscle actin (α-SMA) were also increased significantly in the miR-133a-3p-Exo group compared to the miR-NC-Exo group (CD31: (2.9±0.9) vs. (13.9±2.0), P<0.000 1, α-SMA: (3.5±0.9) vs. (11.0±1.6), P<0.000 1). Conclusion: Exosome derived from miR-133a-3p engineered ucMSC effectively inhibited myocardial apoptosis and promoted angiogenesis, thus improving the cardiac function after myocardial infarction in rats. 目的: 探讨miR-133a-3p修饰的人源脐带血间充质干细胞(ucMSC)衍生的外泌体对急性心肌梗死(AMI)后大鼠心肌修复的作用。 方法: 体外扩增培养ucMSC,将携带miR-133a-3p的慢病毒载体及阴性对照载体分别转染至ucMSC,分别提取其分泌的外泌体,命名为miR-133a-3p-Exo及miR-NC-Exo。采用冠状动脉左前降支结扎术构建大鼠AMI模型,分别于梗死区边缘原位注射miR-133a-3p-Exo或miR-NC-Exo进行干预。干预后28 d,采用超声心动图检测大鼠心功能;采用Masson染色检测大鼠梗死后心肌纤维化面积;采用TUNEL染色评估梗死后大鼠心肌凋亡情况;采用免疫荧光染色评估梗死后大鼠血管新生情况。 结果: 与miR-NC-Exo组相比,miR-133a-3p-Exo组在AMI后28 d左心室射血分数较高[(64.2%±8.9%)比(47.4%±9.8%),P<0.05],心肌纤维化面积[(18.0%±1.5%)比(31.2%±7.3%),P<0.01]和凋亡率[(15.1%±4.4%)比(25.6%±3.6%),P<0.05]较低;梗死边缘区血小板-内皮黏附因子(CD31)及平滑肌肌动蛋白(α-SMA)阳性血管的数量均较多[CD31:(13.9±2.0)条比(2.9±0.9)条,α-SMA:(11.0±1.6)条比(3.5±0.9)条,P均<0.000 1]。 结论: miR-133a-3p修饰的ucMSC分泌的外泌体可有效抑制梗死后心肌凋亡、促进梗死后血管新生,从而改善AMI后大鼠的心功能。.
引用
- Sun, Zhu, Zhang, et al. [Exosomes derived from miR-133a-3p engineered mesenchymal stem cells promote myocardial repair in rats after acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 38220458. doi:10.3760/cma.j.cn112148-20231008-00243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。